Results 141 to 150 of about 983,966 (332)
Metabolic Consequences of Rheumatoid Arthritis
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry+2 more
wiley +1 more source
Chuchu Churko,1 Manaye Yihune,2 Abinet Teshome,3 Yilma Chisha,2 Birhanu Getachew,4 Markos Sleshi,4 Mekuria Asnakew Asfaw,1 Tamiru Shibiru,5 Nebiyu Negussu Ayele,6 Fikre Seife,6 Zerihun Zerdo,1 Alemayehu Bekele Kassahun1 1Collaborative Research and ...
Churko C+11 more
doaj
Objective The objective of this study was to evaluate and compare the risk of hepatotoxicity associated with the use of febuxostat and benzbromarone in patients with gout. Methods New users of febuxostat or benzbromarone with monitoring of liver function at least three times in a year after initiation of the study drugs were identified from an ...
Wenyan Sun+8 more
wiley +1 more source
Impact of Five Annual Rounds of Mass Drug Administration with Diethylcarbamazine and Albendazole on Wuchereria bancrofti Infection in American Samoa [PDF]
Jennifer L. Liang+5 more
openalex +1 more source
Objective The Plants for Joints (PFJ) intervention, including a whole‐food plant‐based diet, exercise, and stress reduction, reduced signs and symptoms of rheumatoid arthritis (RA) or metabolic syndrome–associated hip or knee osteoarthritis (MSOA) compared to usual care.
Carlijn A. Wagenaar+10 more
wiley +1 more source
The promise and pitfalls of mass drug administration to control intestinal helminth infections [PDF]
Debbie Humphries+4 more
openalex +1 more source
Objective This study investigated whether sleep disturbance can predict the extent to which pain interferes with daily functioning in patients with early rheumatoid arthritis (RA). Methods Data were from adults with early RA (joint symptoms ≤12 months) enrolled in the Canadian Early Arthritis Cohort between 2016 and 2023.
Burcu Aydemir+16 more
wiley +1 more source
Current and Future Cornea Chip Models for Advancing Ophthalmic Research and Therapeutics
This review analyzes cornea chip technology as an innovative solution to corneal blindness and tissue scarcity. The examination encompasses recent developments in biomaterial design and fabrication methods replicating corneal architecture, highlighting applications in drug screening and disease modeling while addressing key challenges in mimicking ...
Minju Kim+3 more
wiley +1 more source
Mass drug administration significantly reduces infection of Schistosoma mansoni and hookworm in school children in the national control program in Sierra Leone [PDF]
Mary H. Hodges+7 more
openalex +1 more source
Situasi Filariasis Setelah Pengobatan Massal Tahun Ketiga di Kabupaten Mamuju Utara [PDF]
Mass Drug Administration (MDA) of lymphatic filariasis has been carried out for three years in North of Mamuju District. However, achievement of efficacy of this programme was unknown.
Anastasia, H. (Hayani)+7 more
core